Advertisement
Advertisement
U.S. markets close in 5 hours 21 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Ayala Pharmaceuticals, Inc. (ADXS)

Other OTC - Other OTC Delayed Price. Currency in USD
Visitors trend2W10W9M
0.89000.0000 (0.00%)
As of 02:58PM EDT. Market open.
Advertisement
Advertisement
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
Total Revenue
1,733
3,506
3,708
2,334
Cost of Revenue
1,643
3,506
3,708
1,285
Gross Profit
90
0
0
1,049
Operating Expense
37,632
39,218
29,777
18,760
Operating Income
-37,542
-39,218
-29,777
-17,711
Net Non Operating Interest Income Expense
-224
-260
56
225
Pretax Income
-37,766
-39,478
-29,721
-17,486
Tax Provision
708
776
425
306
Net Income Common Stockholders
-38,474
-40,254
-30,146
-17,792
Diluted NI Available to Com Stockholders
-38,474
-40,254
-30,146
-17,792
Basic EPS
-
-2.80
-3.06
-2.07
Diluted EPS
-
-2.80
-3.06
-2.07
Basic Average Shares
-
14,399
9,861
8,580
Diluted Average Shares
-
14,399
9,861
8,580
Total Operating Income as Reported
-37,542
-39,218
-29,777
-17,711
Total Expenses
39,275
42,724
33,485
20,045
Net Income from Continuing & Discontinued Operation
-38,474
-40,254
-30,146
-17,792
Normalized Income
-38,474
-40,254
-30,146
-17,792
Interest Income
-
-
56
225
Interest Expense
-
260
-
-
Net Interest Income
-224
-260
56
225
EBIT
-37,542
-39,218
-29,777
-17,711
EBITDA
-37,393
-39,050
-29,595
-17,561
Reconciled Cost of Revenue
1,643
3,506
3,708
1,285
Reconciled Depreciation
149
168
182
150
Net Income from Continuing Operation Net Minority Interest
-38,474
-40,254
-30,146
-17,792
Normalized EBITDA
-37,393
-39,050
-29,595
-17,561
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
Advertisement
Advertisement